Share

Glenhill Advisors buys $180685734 stake in Allscripts Healthcare Solutions Inc (MDRX)

It has ranged in price between $12.7-$12.92 after having started the session at $12.88 as compared to the previous trading day’s close of $12.88. The share price of the stock plunged -1.38% for the year. Allscripts Healthcare Solutions Inc makes up approx 0.01% of Old Mutual Global Investors (uk) Ltd.’s portfolio.Ls Investment Advisors boosted its stake in MDRX in the latest quarter, The investment management firm added 4,833 additional shares and now holds a total of 12,246 shares of Allscripts Healthcare Solutions Inc which is valued at $169,240.

Advertisement

The share price of Allscripts Healthcare Solutions, Inc. The stock has a market capitalization of $2.45 billion and a PE ratio of 821.25. The stock was sold at an average price of $13.04, for a total value of $195,600.00. Underperform rating was given by 1 analyst and Outperform rating was given by 7 analyst.

Many Wall Street Analysts have commented on Allscripts Healthcare Solutions Inc.

Cowen & Co. has downgraded Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) from Outperform to Market Perform in a statement released on 9/8/2016. The company reported $0.14 earnings per share for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.14. The firm earned $386.50 million during the quarter, compared to analysts’ expectations of $403.13 million.

Presently, Analysts decided consensus EPS estimate of $0.15 for present quarter and one month ago projected EPS estimate was at $0.15. The stock had a trading volume of 2.1 M shares. Allscripts Healthcare Solutions Inc makes up approx 0.01% of Ls Investment Advisors’s portfolio. Bank of Montreal Can acquired a new position in shares of Allscripts Healthcare Solutions during the second quarter worth about $414,000. Gross margin was 39.6%, operating expenses were $270.7 million, operating income was $5.7 million, and net loss was $5.7 million, or a loss of $0.04 per share based on 127.5 million weighted average shares outstanding. 14 advised “Hold Rating” regarding the stock. The company finished it is trading at $12.88. Finally, A.R.T. Advisors LLC acquired a new stake in shares of Allscripts Healthcare Solutions during the first quarter worth $167,000. KeyCorp reissued a “hold” rating on shares of Allscripts Healthcare Solutions in a research report on Sunday, May 22nd. (NASDAQ:MDRX)’s stock. The average target is fixed at 16.15, and depicts the mean view of 10 brokerages, who have been tracing the stock for the past few months.

Analysts are expecting that the company to achieve $16.09 Price Target in next 52-weeks, average price is come up through the consensus of analysts. The impact score of Allscripts Healthcare Solutions, Inc.

Advertisement

Allscripts eRecruit, the initial offering of Allscripts Clinical Trials Solutions, enables more effective clinical trials recruitment from Allscripts broad provider network and large patient population. eRecruit focuses specifically on helping CROs determine if a trial is feasible within the Allscripts population, and facilitating enrollment of the qualified patients the trial requires. The Clinical and Financial Solutions segment includes the sale of integrated clinical software applications and financial and information solutions, which primarily include electronic health record (EHR)-related software, financial and practice management software, related installation, support and maintenance, outsourcing, hosting, revenue cycle management, training and electronic claims administration services. Our innovative solutions connect people, places and data across an Open, Connected Community of Health™.

Allscripts Healthcare Solutions Inc. (MDRX) Lowered to 'Market Perform' at Cowen and Company